Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression
by
Fazio, Vito M.
, Wisman, G. Bea A.
, Brait, Mariana
, Sidransky, David
, Begum, Shahnaz
, de Graeff, Pauline
, Barbosa, Alvaro
, Rabitti, Carla
, Angioli, Roberto
, Marchionni, Luigi
, Poeta, Maria Luana
, Hoque, Mohammad O.
, J. van der Zee, Ate G.
, Loyo, Myriam
, Maldonado, Leonel
, Noordhuis, Maartje
in
Aberration
/ Adenomatous polyposis coli
/ Adult
/ Aged
/ Azacitidine - analogs & derivatives
/ Azacitidine - pharmacology
/ Base Sequence
/ Bioindicators
/ Biological effects
/ Biomarkers
/ Cancer
/ Cohort Studies
/ Confidence intervals
/ Data processing
/ Decitabine
/ Design of experiments
/ Disease Progression
/ DNA Methylation
/ DNA Primers
/ Epigenetics
/ ESR1 protein
/ Experimental design
/ Female
/ Glutathione transferase
/ Health risk assessment
/ Humans
/ Methylation
/ Middle Aged
/ Multivariate analysis
/ Nerve Growth Factors - genetics
/ Ovarian cancer
/ Ovarian carcinoma
/ Ovarian Neoplasms - genetics
/ Ovarian Neoplasms - pathology
/ Promoter Regions, Genetic
/ Quality
/ Real-Time Polymerase Chain Reaction
/ Reverse Transcriptase Polymerase Chain Reaction
/ Survival
/ Tumors
/ Ubiquitin Thiolesterase - genetics
2013
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression
by
Fazio, Vito M.
, Wisman, G. Bea A.
, Brait, Mariana
, Sidransky, David
, Begum, Shahnaz
, de Graeff, Pauline
, Barbosa, Alvaro
, Rabitti, Carla
, Angioli, Roberto
, Marchionni, Luigi
, Poeta, Maria Luana
, Hoque, Mohammad O.
, J. van der Zee, Ate G.
, Loyo, Myriam
, Maldonado, Leonel
, Noordhuis, Maartje
in
Aberration
/ Adenomatous polyposis coli
/ Adult
/ Aged
/ Azacitidine - analogs & derivatives
/ Azacitidine - pharmacology
/ Base Sequence
/ Bioindicators
/ Biological effects
/ Biomarkers
/ Cancer
/ Cohort Studies
/ Confidence intervals
/ Data processing
/ Decitabine
/ Design of experiments
/ Disease Progression
/ DNA Methylation
/ DNA Primers
/ Epigenetics
/ ESR1 protein
/ Experimental design
/ Female
/ Glutathione transferase
/ Health risk assessment
/ Humans
/ Methylation
/ Middle Aged
/ Multivariate analysis
/ Nerve Growth Factors - genetics
/ Ovarian cancer
/ Ovarian carcinoma
/ Ovarian Neoplasms - genetics
/ Ovarian Neoplasms - pathology
/ Promoter Regions, Genetic
/ Quality
/ Real-Time Polymerase Chain Reaction
/ Reverse Transcriptase Polymerase Chain Reaction
/ Survival
/ Tumors
/ Ubiquitin Thiolesterase - genetics
2013
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression
by
Fazio, Vito M.
, Wisman, G. Bea A.
, Brait, Mariana
, Sidransky, David
, Begum, Shahnaz
, de Graeff, Pauline
, Barbosa, Alvaro
, Rabitti, Carla
, Angioli, Roberto
, Marchionni, Luigi
, Poeta, Maria Luana
, Hoque, Mohammad O.
, J. van der Zee, Ate G.
, Loyo, Myriam
, Maldonado, Leonel
, Noordhuis, Maartje
in
Aberration
/ Adenomatous polyposis coli
/ Adult
/ Aged
/ Azacitidine - analogs & derivatives
/ Azacitidine - pharmacology
/ Base Sequence
/ Bioindicators
/ Biological effects
/ Biomarkers
/ Cancer
/ Cohort Studies
/ Confidence intervals
/ Data processing
/ Decitabine
/ Design of experiments
/ Disease Progression
/ DNA Methylation
/ DNA Primers
/ Epigenetics
/ ESR1 protein
/ Experimental design
/ Female
/ Glutathione transferase
/ Health risk assessment
/ Humans
/ Methylation
/ Middle Aged
/ Multivariate analysis
/ Nerve Growth Factors - genetics
/ Ovarian cancer
/ Ovarian carcinoma
/ Ovarian Neoplasms - genetics
/ Ovarian Neoplasms - pathology
/ Promoter Regions, Genetic
/ Quality
/ Real-Time Polymerase Chain Reaction
/ Reverse Transcriptase Polymerase Chain Reaction
/ Survival
/ Tumors
/ Ubiquitin Thiolesterase - genetics
2013
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression
Journal Article
Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression
2013
Request Book From Autostore
and Choose the Collection Method
Overview
To elucidate the role of biological and clinical impact of aberrant promoter hypermethylation (PH) in ovarian cancer (OC).
PH of PGP9.5, HIC1, AIM1, APC, PAK3, MGMT, KIF1A, CCNA1, ESR1, SSBP2, GSTP1, FKBP4 and VGF were assessed by quantitative methylation specific PCR (QMSP) in a training set. We selected two genes (VGF and PGP9.5) for further QMSP analysis in a larger independent validation (IV) set with available clinical data. Biologic relevance of VGF gene was also evaluated.
PH frequency for PGP9.5 and VGF were 85% (316/372) and 43% (158/366) respectively in the IV set of samples while no PH was observed in controls. In 372 OC cases with available follow up, PGP9.5 and VGF PH were correlated with better patient survival [Hazard Ratios (HR) for overall survival (OS) were 0.59 (95% Confidence Intervals (CI) = 0.42-0.84, p = 0.004), and 0.73 (95%CI = 0.55-0.97, p = 0.028) respectively, and for disease specific survival (DSS) were 0.57 (95%CI 0.39-0.82, p = 0.003) and 0.72 (95%CI 0.54-0.96, p = 0.027). In multivariate analysis, VGF PH remained an independent prognostic factor for OS (HR 0.61, 95%CI 0.43-0.86, p<0.005) and DSS (HR 0.58, 95%CI 0.41-0.83, p<0.003). Furthermore, PGP9.5 PH was significantly correlated with lower grade, early stage tumors, and with absence of residual disease. Forced expression of VGF in OC cell lines inhibited cell growth.
Our results indicate that VGF and PGP9.5 PH are potential biomarkers for ovarian carcinoma. Confirmatory cohorts with longitudinal follow-up are required in future studies to define the clinical impact of VGF and PGP9.5 PH before clinical application.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
MBRLCatalogueRelatedBooks
Related Items
Related Items
This website uses cookies to ensure you get the best experience on our website.